SLNO - Company ID 0001484565
The table below shows SOLENO THERAPEUTICS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $190.41M | - | - | - | - | - |
| Cost of revenue | $2.70M | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $40.63M | $78.57M | $25.19M | $15.27M | $21.45M | $23.19M |
| SG&A |
SOLENO THERAPEUTICS INC reported annual revenue of $190.41M for fiscal year 2025. That is up 13024.2% from $1.45M in fiscal 2016. Over the 5 fiscal years shown, annual revenue grew from $3.00M (FY 2013) to $190.41M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $132.13M |
| $105.86M |
| $13.48M |
| $9.84M |
| $10.81M |
| $8.76M |
| Operating income | $9.41M | -$187.67M | -$41.38M | -$24.40M | -$31.53M | -$36.29M |
| Income tax | $0.00 | $0.00 | $0.00 | - | - | - |
| Net income | $20.89M | -$175.85M | -$38.99M | -$24.07M | -$30.91M | -$24.64M |
| EPS (diluted) | $0.39 | -$4.38 | -$2.36 | -$2.87 | -$5.81 | - |